Decreasing Cost of Sequencing Leading to the Growth of the USA Genome Sequencing Market During 2020-25

The USA Genome Sequencing market is projected to grow at a high rate in the forecast period on an account of affordable sequencing technologies and decrease in the cost of sequencing. The rapid revolution in the field of human genetics in the applications of genomics, bolstering initiatives, and funding by the government to promote genome sequencing. Along with this, launch of sequencing instruments and reagent kits and increasing presence of new players and start-ups in the country are imposing a significant influence on the growth of Genome Sequencing market in the forthcoming years.

According to MarkNtel Advisors’ research report titled “The USA Genome Sequencing Market Analysis, 2020”, the USA Genome Sequencing market is anticipated to grow at a considerable CAGR during 2020-25. Based on Application, Biomarker & Cancer acquired the significant market share in the USA Genome Sequencing market in 2019 on an account of subsequent rise in the incidence of cancer in the country.

“The USA Genome Sequencing Market Analysis, 2020” provides comprehensive qualitative and quantitative insights on the industry potential, key factors impacting sales and purchase decisions, hotspots, and growth opportunities available for Genome Sequencing providers across the region. Moreover, the report also encompasses the key strategic imperatives for success for competitors along with strategic factorial indexing measuring competitor's capabilities on 16 parameters. This will help companies in the formulation of Go to Market Strategies and identifying the blue ocean for its offerings

Hospitals & Clinics Exhibited Fastest Growth

Based on End User, Hospitals & Clinics is expected to attain highest CAGR by 2025 on an account of increasing use of genome sequencing in clinical practices since before, it was only restricted to research activities. Moreover, surging government investment to support rapid transitioning of genome sequencing into clinical practice and implementation into healthcare systems along with the workforce and infrastructure development of healthcare industry along with rising number of patients with cancer or rare diseases are expected to boost the genome sequencing in clinical practices as stated by the MarkNtel Advisors’ research report “The USA Genome Sequencing Market Analysis, 2020”. 

According to MarkNtel Advisors, the key players with a considerable market share in the USA Genome Sequencing market are Abbott, Roche, Agilent, Perkinelmer, Siemens, Illumina, ThermoFisher, Pacific Biosciences, Integrated DNA Technologies, Cytiva etc.  

Market Segmentation:

1. By Product (Consumables, Instruments, Services)
2. By Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Pyrosequencing, Sequencing by Ligation, Chain Termination Technology, Single-Molecule Real-Time Sequencing, Nanopore Sequencing, Others)
3. By Application (Biomarker & Cancer, Personalized medicine, Forensic, Reproductive Health, Diagnostics, Others)
4. By End-User (Hospitals & Clinics, Academic & government research institute, Biotechnology & Pharmaceutical Companies)
5. By Country (South, West, Northeast, Midwest),
6. By Company (Abbott, Roche, Agilent, Perkinelmer, Siemens, Illumina, ThermoFisher, Pacific Biosciences, Integrated DNA Technologies, Cytiva etc.)

Key questions answered in the study:

1. What are the current and future trends of the Genome Sequencing industry?
2. How the industry has been evolving in terms of end-user demand and application areas?
3. How the competition has been shaping across the region followed by their comparative factorial indexing?
4. What are the key growth drivers and challenges for the Genome Sequencing industry?
5. What is the customer orientation, purchase behavior, and expectations from the Genome Sequencing firms across various regions?